MAPT and Alzheimer disease: For example, previous studies indicated that AD patients with comorbid cerebrovascular disease showed tau pathology in lower Braak stages,15 and the presence of Lewy bodies and TAR DNA‐binding protein 43 (TDP‐43) co‐pathology has been associated with faster cognitive decline in AD.16, 17, 18